Connect with us
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped more than 100% in early-morning trading Friday after the psychedelic drug developer announced a $35 million private placement,...
The Open:Minds Expo will focus on introducing consumers to psychedelic therapy and offer training programs for practitioners. As Colorado works to finalize rules around its soon-to-come...
Bright Minds says nothing has material has changed in response to the stock move. Psychedelic drug company Bright Minds Biosciences Inc. (NASDAQ: DRUG) saw its stock...
A New Hampshire legislative committee on Wednesday tabled a bill that would have legalized certain psychedelics for medical reasons, saying that not enough research into medical...
Election day is just a month away, and this year millions of voters will decide the fates of at least seven pro-cannabis and psychedelic ballot measures...
Massachusetts voters next month will have the chance to legalize five different psychedelic drugs for use in treating mental health disorders, with Question 4 on the...
The Drug Enforcement Administration has rejected witnesses and testimony from the group fighting to keep two psychedelic compounds out of Schedule I. The agency has a...
The Harvard contract comes as the prestigious university renews its focus on psychedelic research. PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTC: MDXXF) will supply MDMA for...
Lobe Sciences, Ltd. (CSE: LOBE), (OTCQB: LOBEF) and Alera Pharma announced the issuance by the United States Patent and Trademark Office (USPTO) of U.S. Patent number...
Colorado officials are extending the public comment period for proposed fees related to the state’s upcoming psychedelic-assisted therapy program, delaying final approval. The Department of Revenue’s...
